Literature DB >> 3708819

Liquid-chromatographic determination of hyaluronic acid in pleural and ascitic fluids.

A Hjerpe.   

Abstract

A previously described method for determination of hyaluronic acid is modified for the analysis of pleural and ascitic fluids. After 20 microL of the acellular supernate is precipitated with ethanol, the precipitate is digested overnight with chondroitinases and chondroitin sulfatases. The content of hyaluronic acid-derived disaccharide is then analyzed by "high-performance" liquid chromatography. The high sensitivity (detection limit, less than 0.1 microgram of hyaluronate-derived uronic acid per milliliter) and reproducibility (SD = 4% of the mean) enable accurate determination of hyaluronic acid, even in effusions from patients without signs of mesothelioma. The range of values obtained for pleural and ascitic fluids from patients without signs of this kind of tumor is the same as that found by using other techniques, being slightly higher in those patients showing signs of tissue destruction. The concentrations of hyaluronic acid were considerably increased in most, but not all, of the cases of mesothelioma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708819

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma.

Authors:  Filip Mundt; Gustav Nilsonne; Sertaç Arslan; Karola Csürös; Gunnar Hillerdal; Huseyin Yildirim; Muzaffer Metintas; Katalin Dobra; Anders Hjerpe
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

2.  Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions.

Authors:  Adam Szulkin; Rita Otvös; Carl-Olof Hillerdal; Aytekin Celep; Eviane Yousef-Fadhel; Henriette Skribek; Anders Hjerpe; László Székely; Katalin Dobra
Journal:  BMC Cancer       Date:  2014-09-24       Impact factor: 4.430

3.  Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.

Authors:  Filip Mundt; Henrik J Johansson; Jenny Forshed; Sertaç Arslan; Muzaffer Metintas; Katalin Dobra; Janne Lehtiö; Anders Hjerpe
Journal:  Mol Cell Proteomics       Date:  2013-12-20       Impact factor: 5.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.